CytoMed Therapeutics

GDTCNasdaq Singapore Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$9.715 M

$0.82 +2.29%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

11,828,435

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#430Theriva BiologicsTOVX$10.1M
#431Aspire BiopharmaASBP$10.0M
#432CytoMed TherapeuticsGDTC$9.71M
#433Lisata TherapeuticsLSTA$9.65M
#434Quoin PharmaceuticalsQNRX$9.62M

Where these numbers come from

Share counts and financials for CytoMed Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.